Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Paul

Showing results (561-570 of 704) with videos related to

Pageof 71
Sort By:
The Journal of Clinical Investigation|September 21, 2010
Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulationRubén Martínez-Barricarte, Meike Heurich, Francisco Valdes-Cañedo, et al.
American Journal of Physiology. Renal Physiology|March 17, 2023
Tacrolimus induces fibroblast-to-myofibroblast transition via a TGF-β-dependent mechanism to contribute to renal fibrosisAdaku C Ume, Tara Y Wenegieme, Jennae N Shelby, et al.
American Journal of Human Genetics|September 26, 2002
Autosomal dominant familial calcium pyrophosphate dihydrate deposition disease is caused by mutation in the transmembrane protein ANKHCharlene J Williams, Yun Zhang, Andrew Timms, et al.
Bone|January 2, 2016
Deletion of the membrane complement inhibitor CD59a drives age and gender-dependent alterations to bone phenotype in miceAnja C Bloom, Fraser L Collins, Rob J Van't Hof, et al.
Molecular Immunology|January 31, 2016
Genetic analysis and functional characterization of novel mutations in a series of patients with atypical hemolytic uremic syndromeNóra Szarvas, Ágnes Szilágyi, Dorottya Csuka, et al.
The Journal of Infectious Diseases|December 31, 2021
Efficacy of an Experimental Gonococcal Lipooligosaccharide Mimitope Vaccine Requires Terminal ComplementLisa A Lewis, Sunita Gulati, Wioleta M Zelek, et al.
Blood|February 19, 2008
Circulating neutrophils maintain physiological blood pressure by suppressing bacteria and IFNgamma-dependent iNOS expression in the vasculature of healthy miceJonathan Morton, Barbara Coles, Kate Wright, et al.
The Journal of Clinical Investigation|September 20, 2011
Complement component 5 contributes to poor disease outcome in humans and mice with pneumococcal meningitisBianca Woehrl, Matthijs C Brouwer, Carmen Murr, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 31, 2014
A novel antibody against human factor B that blocks formation of the C3bB proconvertase and inhibits complement activation in disease modelsMarta Subías, Agustín Tortajada, Sara Gastoldi, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|October 2, 2012
In vitro perturbations of targets in cancer hallmark processes predict rodent chemical carcinogenesisNicole C Kleinstreuer, David J Dix, Keith A Houck, et al.
Pageof 71

Showing results (561-570 of 704) with videos related to

Sort By:
Pageof 71
The Journal of Clinical Investigation|September 21, 2010
Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulationRubén Martínez-Barricarte, Meike Heurich, Francisco Valdes-Cañedo, et al.
American Journal of Physiology. Renal Physiology|March 17, 2023
Tacrolimus induces fibroblast-to-myofibroblast transition via a TGF-β-dependent mechanism to contribute to renal fibrosisAdaku C Ume, Tara Y Wenegieme, Jennae N Shelby, et al.
American Journal of Human Genetics|September 26, 2002
Autosomal dominant familial calcium pyrophosphate dihydrate deposition disease is caused by mutation in the transmembrane protein ANKHCharlene J Williams, Yun Zhang, Andrew Timms, et al.
Bone|January 2, 2016
Deletion of the membrane complement inhibitor CD59a drives age and gender-dependent alterations to bone phenotype in miceAnja C Bloom, Fraser L Collins, Rob J Van't Hof, et al.
Molecular Immunology|January 31, 2016
Genetic analysis and functional characterization of novel mutations in a series of patients with atypical hemolytic uremic syndromeNóra Szarvas, Ágnes Szilágyi, Dorottya Csuka, et al.
The Journal of Infectious Diseases|December 31, 2021
Efficacy of an Experimental Gonococcal Lipooligosaccharide Mimitope Vaccine Requires Terminal ComplementLisa A Lewis, Sunita Gulati, Wioleta M Zelek, et al.
Blood|February 19, 2008
Circulating neutrophils maintain physiological blood pressure by suppressing bacteria and IFNgamma-dependent iNOS expression in the vasculature of healthy miceJonathan Morton, Barbara Coles, Kate Wright, et al.
The Journal of Clinical Investigation|September 20, 2011
Complement component 5 contributes to poor disease outcome in humans and mice with pneumococcal meningitisBianca Woehrl, Matthijs C Brouwer, Carmen Murr, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 31, 2014
A novel antibody against human factor B that blocks formation of the C3bB proconvertase and inhibits complement activation in disease modelsMarta Subías, Agustín Tortajada, Sara Gastoldi, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|October 2, 2012
In vitro perturbations of targets in cancer hallmark processes predict rodent chemical carcinogenesisNicole C Kleinstreuer, David J Dix, Keith A Houck, et al.
Pageof 71